Can-Fite BioPharma (CANF) Income from Non-Controlling Interests (2014 - 2017)
Can-Fite BioPharma (CANF) recorded Income from Non-Controlling Interests of -$176,000 in Q4 2017, compared with $66,000 a year earlier.
Powered by 
Analysis
Can-Fite BioPharma (CANF) Income from Non-Controlling Interests (2014 - 2017) Analysis & Trends
For FY2017, Can-Fite BioPharma reported Income from Non-Controlling Interests of -$94,000.
- Across earlier years, Income from Non-Controlling Interests came in at $136,000 in FY2016 (-48.9%) and $266,000 in FY2015.
- The Q4 2017 figure is the lowest quarterly Income from Non-Controlling Interests in data going back to Q1 2014.
- On a year-over-year basis, Income from Non-Controlling Interests rose in two of the last six quarters, with an average decline of 20.3%.
- Peak year-over-year performance for Income from Non-Controlling Interests in the last five years was growth of 93.8% in Q2 2015, against a decline of 89.2% in Q1 2016 at the low end.
- Per Business Quant, the preceding three quarters came in at $29,000 (Q3 2017), $74,000 (Q2 2017) and -$21,000 (Q1 2017).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | - |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.00 Mn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -2.00 Mn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -7.00 Mn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 1.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 10.00 Mn |
| 10 | Can-Fite BioPharma | 1.79 Mn | -17.91 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2017 | -176,000.00 |
| Sep 30, 2017 | 29,000.00 |
| Jun 30, 2017 | 74,000.00 |
| Mar 31, 2017 | -21,000.00 |
| Dec 31, 2016 | 66,000.00 |
| Sep 30, 2016 | 27,000.00 |
| Jun 30, 2016 | 39,000.00 |
| Mar 31, 2016 | 4,000.00 |
| Dec 31, 2015 | 109,000.00 |
| Sep 30, 2015 | 58,000.00 |
| Jun 30, 2015 | 62,000.00 |
| Mar 31, 2015 | 37,000.00 |
| Sep 30, 2014 | 42,000.00 |
| Jun 30, 2014 | 32,000.00 |
| Mar 31, 2014 | 67,000.00 |
API Access
Can-Fite BioPharma Income from Non-Controlling Interests API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=CANF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-non-controlling-interests", "ticker": "CANF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=CANF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();